IP Library Granted Patent US 10,160,789
Granted Patent B2
US 10,160,789 · App. 14/005,388 · Granted Dec 25, 2018

Polypeptides having immunoactivating activity and methods of producing the same

Inventors: Nobuyuki Matoba (Owensboro, KY); Krystal Hamorsky (Owensboro, KY)
Assignee: University of Louisville Research Foundation, Inc.
C07K14/28A61K39/107C12N15/8258A61K38/00A61K2039/542C07K2319/02C07K2319/04Y02A50/472
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,160,789
App. No.
14/005,388
Granted
Dec 25, 2018
Kind
B2
Abstract

Isolated polypeptides are provided that comprise a cholera toxin B subunit variant having one or more modifications to increase the expression of the polypeptide in a plant cell. Nucleic acids sequences, vectors, and plant cells for expressing the cholera toxin B subunit variant polypeptides are also provided. Further provided are methods for producing the cholera toxin B subunit variant polypeptides that include the steps of transforming a plant cell with a nucleic acid encoding the cholera toxin B subunit variant polypeptides; expressing the variant polypeptides; and purifying the polypeptides. Still further provided are methods of isolating the variant polypeptides that include the steps of obtaining a plant cell expressing the cholera toxin B subunit variant polypeptides; extracting the cholera toxin B subunit variant polypeptides from the plant cell; and purifying the cholera toxin B subunit variant polypeptides. Methods of eliciting an immune response are also provided.

Claims (6)

1. An isolated polypeptide produced in a plant cell, the isolated polypeptide comprising the sequence of SEQ ID NO: 4.

2. The polypeptide of claim 1 , wherein the polypeptide further comprises a secretory signal peptide selected from the group consisting of a rice alpha-amylase secretory signal peptide, a Nicotiana plumbagenifolia calreticulin secretory signal peptide, an apple pectinase secretory signal peptide, and a barley alpha-amylase secretory signal peptide.

3. The polypeptide of claim 2 , wherein the secretory signal peptide has an amino acid sequence selected from the group consisting of SEQ ID NOS: 18, 20, 22,and 24.

4. The polypeptide of claim 2 , wherein the secretory signal peptide comprises the rice alpha-amylase secretory signal peptide.

5. A pharmaceutical composition comprising the polypeptide of claim 1 and a pharmaceutically-acceptable vehicle, carrier, or excipient.

6. The pharmaceutical composition of claim 5 , wherein the pharmaceutical composition further comprises an adjuvant.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF INVENTOR NOBUYUKI MATOBA, AND TO UPDATE THE ATTORNEY DOCKET NUMBER AND CORRESPONDENCE DATA PREVIOUSLY RECORDED ON REEL 031375 FRAME 0982. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 18, 2018
From: MATOBA, NOBUYUKI; HAMORSKY, KRYSTAL
To: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
Reel/Frame 047271/0879 →
CONFIRMATORY LICENSE Recorded Jun 26, 2014
From: UNIVERSITY OF LOUISVILLE
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 033186/0358 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2013
From: MATOBI, NOBUYUKI; HAMORSKY, KRYSTAL
To: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC.
Reel/Frame 031375/0982 →
Continuity (2)
Provisional Application 61452308 · Mar 14, 2011
Related Publication 20140286986A1 · Sep 25, 2014
Cited By (1)
US 12,343,375